VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE
· Real-Time Price · USD
0.40
-1.04 (-72.22%)
At close: Jul 30, 2025, 3:59 PM
VYNE Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 605K | 501K | 493K | 486K | 423K | 424K | 354K | 407K | 398K | 477K | 2.76M | 6.68M | 10.81M | 14.76M | 16.75M | 15.93M | 23.36M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12K | 12K | 915K | 1.96M | 2.75M | 3.35M | 2.98M | 2.3M | 1.72M |
Gross Profit | 399K | 497K | 493K | 486K | 423K | 424K | 354K | 407K | 386K | 465K | 1.85M | 4.72M | 8.07M | 11.41M | 13.77M | 13.63M | 21.64M |
Operating Income | -44.86M | -43.64M | -37.7M | -30.84M | -30.76M | -29.26M | -30.41M | -33.51M | -31.48M | -34.3M | -38.35M | -11.25M | -21.74M | -32.48M | 462.67M | 421.4M | 273M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | 568K |
Pretax Income | -42.16M | -39.8M | -33.95M | -27.86M | -28.5M | -27.87M | -29.47M | -32.65M | -30.85M | -33.93M | -38.2M | -50.23M | -61.92M | -73.78M | -84.94M | -88.37M | -236.14M |
Net Income | -42.19M | -39.81M | -33.98M | -28.41M | -29.07M | -28.45M | -30.02M | -32.9M | -31.32M | -21.03M | -24.84M | -36.66M | -48.11M | -73.33M | -84.94M | -88.37M | -235.88M |
Selling & General & Admin | 12.7M | 13.19M | 13.91M | 13.97M | 13.9M | 13.38M | 13.2M | 14.13M | 15.21M | 16.39M | 20.87M | 30.75M | 42.28M | 54.48M | 64.19M | 70.12M | 80.74M |
Research & Development | 33.36M | 30.95M | 24.29M | 17.36M | 17.28M | 16.31M | 17.56M | 19.79M | 16.67M | 18.39M | 19.34M | 20.78M | 23.08M | 24.96M | 27.56M | 27.2M | 33.91M |
Other Expenses | 1M | 2.14M | 2.82M | 2.98M | 2.26M | 1.39M | 942K | 857K | 629K | 363K | 153K | 40K | -81K | -135K | 949K | 854K | -83.8M |
Operating Expenses | 46.06M | 44.14M | 38.19M | 31.33M | 31.19M | 29.68M | 30.77M | 33.92M | 31.88M | 34.77M | 40.22M | 51.53M | 65.36M | 79.44M | 91.75M | 97.32M | 114.66M |
Interest Expense | n/a | n/a | 263K | 263K | 263K | 263K | 2.34M | 2.34M | 2.34M | 2.34M | 3K | 3.48M | 4.55M | 5.61M | 6.69M | 4.45M | 4.46M |
Selling & Marketing Expenses | n/a | n/a | -9.49M | -9.49M | -9.49M | -9.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 36.66M | 44.14M | 38.19M | 31.33M | 31.19M | 29.68M | 30.77M | 33.92M | 31.88M | 34.77M | 41.12M | 53.48M | 68.11M | 82.79M | 94.73M | 99.62M | 116.38M |
Income Tax Expense | 23K | 23K | 56K | 569K | 578K | 580K | 556K | 247K | 468K | -12.91M | -13.37M | -10.13M | -9.37M | 5M | 5.19M | 1.75M | 489K |
Shares Outstanding (Basic) | 42.67M | 42.59M | 42.59M | 42.59M | 42.58M | 31.05M | 3.28M | 3.27M | 3.26M | 2.98M | 3.22M | 3.22M | 3.08M | 2.97M | 2.89M | 2.86M | 2.71M |
Shares Outstanding (Diluted) | 42.67M | 42.59M | 42.59M | 42.59M | 42.58M | 31.05M | 3.28M | 3.27M | 3.26M | 2.98M | 3.22M | 3.22M | 3.08M | 2.97M | 2.89M | 2.86M | 2.71M |
EPS (Basic) | -0.99 | -0.94 | -0.86 | -2.58 | -5.44 | -7.01 | -9.41 | -10.34 | -9.89 | -6.65 | -7.94 | -12.36 | -16.71 | -25.8 | -30.45 | -33.7 | -113.67 |
EPS (Diluted) | -0.99 | -0.94 | -0.86 | -2.58 | -5.44 | -7.01 | -9.41 | -10.34 | -9.89 | -6.65 | -7.94 | -12.36 | -16.71 | -25.8 | -30.45 | -33.7 | -113.67 |
EBITDA | -43.86M | -42.64M | -36.7M | -29.84M | -30.48M | -28.98M | -29.89M | -32.82M | -31.06M | -33.84M | -38.08M | -39.69M | -50.24M | -61.05M | -71.07M | -83.71M | -231.42M |
EBIT | -35.5M | -42.88M | -37.7M | -30.84M | -30.48M | -28.98M | -29.89M | -32.99M | -31.24M | -34.06M | -38.33M | -39.8M | -41.12M | -42.24M | -52.32M | -65.14M | -222.16M |
Depreciation & Amortization | 1M | 228K | -31K | -70.59K | -949.5K | -130.92K | -30.92K | 179.67K | 69.58K | 72K | 253K | 110K | 126K | 109K | 170K | 209K | 275K |